These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 33253720)

  • 1. Spirulina inhibits hepatocellular carcinoma through activating p53 and apoptosis and suppressing oxidative stress and angiogenesis.
    Mahmoud YI; Shehata AMM; Fares NH; Mahmoud AA
    Life Sci; 2021 Jan; 265():118827. PubMed ID: 33253720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of Diethylnitrosamine-Initiated and Phenobarbital-Promoted Hepatocarcinogenesis in Rats by Sulfated Polysaccharides and Aqueous Extract of Ulva lactuca.
    Hussein UK; Mahmoud HM; Farrag AG; Bishayee A
    Integr Cancer Ther; 2015 Nov; 14(6):525-45. PubMed ID: 26130745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemo-prophylactic efficacy of an ethanol Moringa oleifera leaf extract against hepatocellular carcinoma in rats.
    Sadek KM; Abouzed TK; Abouelkhair R; Nasr S
    Pharm Biol; 2017 Dec; 55(1):1458-1466. PubMed ID: 28345375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbelliferon-α-d-glucopyranosyl-(2
    Kumar V; Bhatt PC; Rahman M; Al-Abbasi FA; Anwar F; Verma A
    Biomed Pharmacother; 2017 Oct; 94():834-842. PubMed ID: 28802237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways.
    Elmansi AM; El-Karef AA; Shishtawy MMEl; Eissa LA
    Ann Hepatol; 2017; 16(4):607-618. PubMed ID: 28611265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-p66(shc)/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma.
    Yang J; Qiu B; Li X; Zhang H; Liu W
    Toxicol Lett; 2015 Nov; 238(3):1-10. PubMed ID: 26222667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel chemoprotective effect of tiopronin against diethylnitrosamine-induced hepatocellular carcinoma in rats: Role of ASK1/P38 MAPK-P53 signalling cascade.
    Mo'men YS; Hussein RM; Kandeil MA
    Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):322-332. PubMed ID: 31663622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of dieckol on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
    Sadeeshkumar V; Duraikannu A; Ravichandran S; Fredrick WS; Sivaperumal R; Kodisundaram P
    Biomed Pharmacother; 2016 Dec; 84():1810-1819. PubMed ID: 27825803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine and S allyl cysteine mediated amelioration of DEN+CCl4 induced hepatocarcinoma.
    Sengupta D; Chowdhury KD; Sarkar A; Paul S; Sadhukhan GC
    Biochim Biophys Acta; 2014 Jan; 1840(1):219-44. PubMed ID: 23999088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of nano-selenium in mitigating hepatocellular carcinoma induced by N-nitrosodiethylamine (NDEA) in rats.
    Ahmed HH; Khalil WK; Hamza AH
    Toxicol Mech Methods; 2014 Dec; 24(8):593-602. PubMed ID: 25156538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boron attenuated diethylnitrosamine induced hepatocellular carcinoma in C3H/HeN mice via alteration of oxidative stress and apoptotic pathway.
    Wei Y; Yi JK; Chen J; Huang H; Wu L; Yin X; Wang J
    J Trace Elem Med Biol; 2022 Dec; 74():127052. PubMed ID: 35952449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Pomegranate Hull Extract on Liver Neoplastic Changes in Rats: More than an Antioxidant.
    El-Ashmawy NE; Khedr EG; El-Bahrawy HA; Abd El-Fattah EE
    Nutr Cancer; 2016; 68(6):1044-51. PubMed ID: 27383944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemopreventive activity of a macrofungus Phellinus rimosus against N-nitrosodiethylamine induced hepatocellular carcinoma in rat.
    Ajith TA; Janardhanan KK
    J Exp Ther Oncol; 2006; 5(4):309-21. PubMed ID: 17024971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats.
    Nishimura N; Kaji K; Kitade M; Aihara Y; Sato S; Seki K; Sawada Y; Takaya H; Okura Y; Kawaratani H; Moriya K; Namisaki T; Mitoro A; Yoshiji H
    BMC Cancer; 2018 Nov; 18(1):1164. PubMed ID: 30477453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria protection with ginkgolide B-loaded polymeric nanocapsules prevents diethylnitrosamine-induced hepatocarcinoma in rats.
    Ghosh S; Dungdung SR; Choudhury ST; Chakraborty S; Das N
    Nanomedicine (Lond); 2014 Mar; 9(3):441-56. PubMed ID: 23742256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.
    Liu Y; Wang W; Fang B; Ma F; Zheng Q; Deng P; Zhao S; Chen M; Yang G; He G
    Eur J Pharmacol; 2013 Jan; 698(1-3):95-102. PubMed ID: 23117090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of rat liver toxicity and carcinogenesis by Spirulina.
    Ismail MF; Ali DA; Fernando A; Abdraboh ME; Gaur RL; Ibrahim WM; Raj MH; Ouhtit A
    Int J Biol Sci; 2009 Jun; 5(4):377-87. PubMed ID: 19521547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.